SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-245492
Filing Date
2021-08-13
Accepted
2021-08-13 08:49:28
Documents
76
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d179444d10q.htm   iXBRL 10-Q 1431907
2 EX-10.1 d179444dex101.htm EX-10.1 31103
3 EX-31.1 d179444dex311.htm EX-31.1 11265
4 EX-31.2 d179444dex312.htm EX-31.2 11287
5 EX-32.1 d179444dex321.htm EX-32.1 4190
6 EX-32.2 d179444dex322.htm EX-32.2 4206
  Complete submission text file 0001193125-21-245492.txt   7000020

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA fstx-20210630.xsd EX-101.SCH 55980
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fstx-20210630_cal.xml EX-101.CAL 46352
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fstx-20210630_def.xml EX-101.DEF 291180
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fstx-20210630_lab.xml EX-101.LAB 487209
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fstx-20210630_pre.xml EX-101.PRE 408401
12 EXTRACTED XBRL INSTANCE DOCUMENT d179444d10q_htm.xml XML 1093346
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 211169898
SIC: 2834 Pharmaceutical Preparations